DT CAD, MB - financials and debts

Company age: 3 y. 6 mo.

Update

DT CAD - Company finances

EUR
2023
From: 2023-04-26
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 98,050 135,255 138,025
Profit before tax 48,714 37,954 46,976
Net profit 48,714 36,056 44,157
Equity 48,814 36,156 44,260
Liabilities 4,838 24,024 26,183
Non-current assets 0 18,914 16,923
Current assets 53,652 41,266 53,520
Total assets 53,652 60,180 70,443
Taxes paid
STI taxes 135 11 1,919
Financial indicators
Revenue change y/y - +37.9% +2.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 90.8% 59.9% 62.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 99.8% 99.7% 99.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 49.7% 26.7% 32.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 49.7% 28.1% 34.0%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.1 0.7 0.6
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

DT CAD - Social security debts

From To Debt, €
2026-04-01 2026-04-30 80.48
2026-02-03 2026-02-28 80.48
2025-12-02 2025-12-31 72.45
2025-02-01 2025-02-28 69.71
2024-05-02 2024-05-31 61.76
2023-06-01 2023-06-30 58.63

DT CAD - VMI tax arrears

From To Overdue, €
2025-06-19 2026-02-03 0.5
2025-02-20 2025-02-27 21.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
DT CAD, MB (code 306306569) is a Small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €138.0K, up 2.0% year on year and 40.8% above the 2023 level. Net profit increased to €44.2K in 2025 from €36.1K in 2024, following €48.7K in 2023, while the profit margin improved to 32.0% from 26.7% a year earlier. Over the three-year period, revenue expanded steadily, while profitability softened in 2024 before recovering in 2025. The balance sheet also strengthened: total assets rose to €70.4K in 2025 from €60.2K in 2024 and €53.7K in 2023, supported by equity of €44.3K and liabilities of €26.2K. The equity ratio stood at 62.8%, with debt-to-equity at 0.59. Asset turnover was 1.96x, indicating efficient use of assets. Return on equity was 99.8% and return on assets 62.7%, reflecting strong earnings relative to the size of the balance sheet.